Problems with prenatal parentage testing between different nationalities.

NIPPT 国籍が違うものの間での出生前親子鑑定の問題点

The issues associated with prenatal paternity testing between international parties are diverse and involve complex legal, ethical, and procedural aspects. The following is a list of typical issues related to international prenatal paternity testing.

1. Legal Differences

  • Differences in legal systems from country to country: Prenatal paternity testing may or may not be legally permitted in different countries. For example, prenatal DNA testing may not be legally allowed in one country or may be very severely restricted. On the other hand, it is allowed in another country, which can create legal problems in international procedures.
  • International law regarding custody and child support: In international marriages and parent-child relationships between foreign nationals, how the results of an evaluation affect the determination of child support and custody varies from country to country. For example, in cross-border cases, the legal process can be complicated by the question of which country’s laws apply.

2. Reliability and recognition of appraisals

  • International recognition of expert testimony: The question may arise as to whether a DNA test performed in one country can be legally validated in another country. In particular, there is a risk that test results may not be legally recognized if there are differing standards for the treatment of evidence and the reliability of test methods between the judicial systems of different countries.

3. A question of ethics.

  • Cultural and Ethical Issues: Acceptance of paternity appraisals varies according to cultural backgrounds and ethical perspectives. While prenatal paternity testing may be generally accepted in one country, it may be opposed from an ethical standpoint in another. Differences in values, particularly those based on religion and culture, can complicate international prenatal testing.

4. Procedural complexity

  • International shipping of specimens: International shipping of DNA specimens requires legal procedures and safe shipping practices. The risk of deterioration, loss, or illegal handling of specimens in international shipments requires that an appropriate chain-of-custody be maintained.
  • Language and communication barriers: If the parties requesting a paternity test live in different countries, language and communication differences may affect the process. If test results are not interpreted or legal procedures are not properly explained, misunderstandings and legal problems may result.

5. Issues related to immigration and nationality

  • Paternity Test for Acquisition of Nationality: In connection with international marriages and immigration, a paternity test may be required in order for a child to acquire the nationality of a certain country. In particular, proof of parent-child relationship is often a condition for obtaining nationality or applying for immigration, and prenatal paternity tests are increasingly being performed for this purpose. However, procedures tend to be complicated because immigration laws and regulations for acquiring nationality differ from country to country.

In an international prenatal paternity test, it is important to have professional support and counseling to understand and accommodate legal and cultural differences. This will help the process go smoothly and minimize problems between the parties.

医師監修 監修日:2024年9月21日

岡 博史 (おか ひろし)

医師・医学博士 ヒロクリニック統括院長

YouTubeチャンネルなどを通じて、遺伝子やNIPT(新型出生前診断)についてわかりやすく発信しています。

略歴

  • 1996年 慶應義塾大学医学部 卒業
  • 2004年 慶應義塾大学 医学博士号 取得
  • 2005年 慶應義塾大学 皮膚科学教室 助手
  • 2008年 ヒロ皮フ形成クリニック 開業
  • 2009年 医療法人社団福美会 理事長
  • 2015年 医療法人社団福美会 理事

資格・所属

  • CAPラボディレクター
  • 日本皮膚科学会 皮膚科専門医
  • 日本医師会 産業医
  • 東京衛生検査所 指導監督医

この記事は、 ヒロクリニックNIPPTの編集・監修体制 にもとづき、資格を持つ医師が内容を確認しています。

医師監修 監修日:2024年9月21日

堤 修一 (つつみ しゅういち)

医師・医学博士 ヒロクリニック博多駅前院 院長

略歴

  • 1993年 東京大学医学部医学科 卒業
  • 2016〜2019年 東京大学先端科学技術研究センター 准教授

発信・関連リンク

この記事は、 ヒロクリニックNIPPTの編集・監修体制 にもとづき、資格を持つ医師が内容を確認しています。

Supervisor of the article


Dr. Hiroshi Oka

Director of CAP Laboratory

Graduated from Keio University, Faculty of Medicine

Doctor of Medicine

Medical Doctor